What is the recommended dosage of dabigatran for patients with end-stage renal disease (CrCl < 15 mL/min or dialysis-dependent) and a TTR > 70%?
In end-stage renal disease (CrCl < 15 mL/min or dialysis-dependent) and a TTR > 70%, the recommended dosage of dabigatran is 75 mg bid in the US, and 150 mg bid (or 110 mg bid outside the US).